Angiotensin II-receptor blockers in bicuspid aortic valve patients with aortic dilation
Author Information
Author(s): Meccanici F., Roos-Hesselink J.W.
Primary Institution: Erasmus University Medical Centre
Hypothesis
Can angiotensin II-receptor blockers effectively slow down aortic dilation in pediatric patients with bicuspid aortic valve?
Conclusion
The study suggests that medical therapy did not significantly affect the rate of aortic dilation in patients with progressive aortic dilation.
Supporting Evidence
- Aortic dilation is common in patients with bicuspid aortic valve, with a prevalence of 0.5–0.8 per 1000 live births.
- Medical therapy has not shown significant effects on aortic dilation in this patient group.
- Previous studies indicated that beta blockers may slow aortic dilation, but evidence is limited.
Takeaway
Doctors are trying to find the best medicine to help kids with a heart problem called bicuspid aortic valve, but the results so far aren't very convincing.
Methodology
The study analyzed aortic diameters in 191 pediatric patients with normally functioning bicuspid aortic valve over a mean follow-up of 3.7 years.
Potential Biases
Selection bias due to medication prescription based on aortic dilation status.
Limitations
The study had selection bias and did not collect blood pressure or heart rate data.
Participant Demographics
Pediatric patients with normally functioning bicuspid aortic valve.
Statistical Information
P-Value
0.280
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website